Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-14 08:56 am Sale | 2021-12-31 | 13G | Exagen Inc. XGN | RTW INVESTMENTS LP | 821,414 5.100% | -428,717 (-34.29%) | Filing History |
| 2022-02-11 7:26 pm Purchase | 2021-12-31 | 13G | Exagen Inc. XGN | Stonepine Capital Management LLC | 858,567 5.300% | 25,030 (+3.00%) | Filing History |
| 2022-02-11 2:09 pm Sale | 2022-02-11 | 13G | Exagen Inc. XGN | WASATCH ADVISORS INC | 1,105,760 6.800% | -585,747 (-34.63%) | Filing History |
| 2022-02-10 4:15 pm Unchanged | 2021-12-31 | 13G | Exagen Inc. XGN | NMSIC Co-Investment Fund L.P. | 2,308,958 14.280% | 0 (Unchanged) | Filing History |
| 2022-02-08 4:10 pm Sale | 2021-12-31 | 13G | Exagen Inc. XGN | Hunt Holdings Limited Partnership | 1,011,324 6.260% | -248,350 (-19.72%) | Filing History |
| 2022-01-20 10:46 am Unchanged | 2021-12-31 | 13G | Exagen Inc. XGN | Cowen Financial Products LLC | 1,384,631 8.570% | 0 (Unchanged) | Filing History |
| 2022-01-19 4:21 pm Purchase | 2021-12-31 | 13G | Exagen Inc. XGN | Cowen Financial Products LLC | 1,384,631 8.570% | 511,000 (+58.49%) | Filing History |
| 2021-12-23 5:33 pm Purchase | 2021-12-20 | 13G | Exagen Inc. XGN | Stonepine Capital Management LLC | 833,537 5.200% | 833,537 (New Position) | Filing History |
| 2021-12-17 3:57 pm Purchase | 2021-09-10 | 13G | Exagen Inc. XGN | Cowen Financial Products LLC | 873,631 5.410% | 873,631 (New Position) | Filing History |
| 2021-04-09 2:00 pm Purchase | 2021-04-09 | 13G | Exagen Inc. XGN | WASATCH ADVISORS INC | 1,691,507 10.000% | 647,104 (+61.96%) | Filing History |
| 2021-02-24 4:32 pm Purchase | 2019-09-23 | 13D | Exagen Inc. XGN | H.I.G. Bio-Exagen L.P. | 1,696,252 13.400% | 1,696,252 (New Position) | Filing History |
| 2021-02-16 10:22 am Sale | 2020-12-31 | 13G | Exagen Inc. XGN | Hunt Holdings Limited Partnership | 1,259,674 9.900% | -219,141 (-14.82%) | Filing History |
| 2021-02-16 06:21 am Sale | 2020-12-31 | 13G | Exagen Inc. XGN | TULLIS DICKERSON CAPITAL FOCUS III L.P. | 1,890,522 14.600% | -243,584 (-11.41%) | Filing History |
| 2021-02-12 09:51 am Purchase | 2021-02-12 | 13G | Exagen Inc. XGN | RTW INVESTMENTS LP | 1,250,131 9.890% | 348,046 (+38.58%) | Filing History |
| 2021-02-11 4:15 pm Sale | 2020-12-31 | 13G | Exagen Inc. XGN | NMSIC Co-Investment Fund L.P. | 2,308,958 18.250% | -125,000 (-5.14%) | Filing History |
| 2021-02-11 2:47 pm Purchase | 2021-02-11 | 13G | Exagen Inc. XGN | WASATCH ADVISORS INC | 1,044,403 8.300% | 1,044,403 (New Position) | Filing History |
| 2020-09-18 4:46 pm Purchase | 2020-09-01 | 13G | Exagen Inc. XGN | NMSIC Co-Investment Fund L.P. | 2,433,958 19.260% | 2,433,958 (New Position) | Filing History |